journal
Journals Clinical and Vaccine Immunolog...

Clinical and Vaccine Immunology : CVI

https://read.qxmd.com/read/28877929/merozoite-surface-protein-1-from-plasmodium-falciparum-is-a-major-target-of-opsonizing-antibodies-in-individuals-with-acquired-immunity-against-malaria
#21
JOURNAL ARTICLE
Anja Jäschke, Boubacar Coulibaly, Edmond J Remarque, Hermann Bujard, Christian Epp
Naturally acquired immunity against malaria is largely mediated by serum antibodies controlling levels of blood-stage parasites. A limited understanding of the antigenic targets and functional mechanisms of protective antibodies has hampered the development of efficient malaria vaccines. Besides directly inhibiting the growth of Plasmodium parasites, antibodies can opsonize merozoites and recruit immune effector cells such as monocytes and neutrophils. Antibodies against the vaccine candidate merozoite surface protein 1 (MSP-1) are acquired during natural infections and have been associated with protection against malaria in several epidemiological studies...
November 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28877928/anthrax-vaccine-precipitated-induces-edema-toxin-neutralizing-edema-factor-specific-antibodies-in-human-recipients
#22
JOURNAL ARTICLE
Eric K Dumas, Timothy Gross, Jason Larabee, Lance Pate, Hannah Cuthbertson, Sue Charlton, Bassam Hallis, Renata J M Engler, Limone C Collins, Christina E Spooner, Hua Chen, Jimmy Ballard, Judith A James, A Darise Farris
Edema toxin (ET), composed of edema factor (EF) and protective antigen (PA), is a virulence factor of Bacillus anthracis that alters host immune cell function and contributes to anthrax disease. Anthrax vaccine precipitated (AVP) contains low but detectable levels of EF and can elicit EF-specific antibodies in human recipients of AVP. Active and passive vaccination of mice with EF can contribute to protection from challenge with Bacillus anthracis spores or ET. This study compared humoral responses to ET in recipients of AVP ( n = 33) versus anthrax vaccine adsorbed (AVA; n = 66), matched for number of vaccinations and time postvaccination, and further determined whether EF antibodies elicited by AVP contribute to ET neutralization...
November 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28877927/protective-vaccine-efficacy-of-the-complete-form-of-ppe39-protein-from-mycobacterium-tuberculosis-beijing-k-strain-in-mice
#23
JOURNAL ARTICLE
Ahreum Kim, Yun-Gyoung Hur, Sunwha Gu, Sang-Nae Cho
The aim of this study was to evaluate the protective efficacy of MTBK_24820, a complete form of PPE39 protein derived from a predominant Beijing/K strain of Mycobacterium tuberculosis in South Korea. Mice were immunized with MTKB_24820, M. bovis Bacilli Calmette-Guérin (BCG), or adjuvant prior to a high-dosed Beijing/K strain aerosol infection. After 4 and 9 weeks, bacterial loads were determined and histopathologic and immunologic features in the lungs and spleens of the M. tuberculosis -infected mice were analyzed...
November 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/29021299/a-randomized-placebo-controlled-double-blind-phase-2-trial-comparing-the-reactogenicity-and-immunogenicity-of-a-single-%C3%A2-2x10-8-colony-forming-units-cfu-standard-dose-versus-a-%C3%A2-2x10-9-cfu-high-dose-of-cvd-103-hgr-live-attenuated-oral-cholera-vaccine-with-shanchol
#24
JOURNAL ARTICLE
Samba O Sow, Milagritos D Tapia, Wilbur H Chen, Fadima C Haidara, Karen L Kotloff, Marcela F Pasetti, William C Blackwelder, Awa Traoré, Boubou Tamboura, Moussa Doumbia, Fatoumata Diallo, Flanon Coulibaly, Uma Onwuchekwa, Mamoudou Kodio, Sharon M Tennant, Mardi Reymann, Diana F Lam, Marc Gurwith, Michael Lock, Thomas Yonker, Jonathan Smith, Jakub K Simon, Myron M Levine
Reactive immunization with a single-dose cholera vaccine that could rapidly (within days) protect immunologically-naïve individuals during "virgin soil" epidemics would facilitate cholera control. One dose of attenuated Vibrio cholerae O1 classical Inaba vaccine CVD 103-HgR (Vaxchora™) containing ≥2x108 colony forming units (cfu) induces vibriocidal antibody seroconversion (correlate of protection) in >90% of U.S. adults. A previous CVD 103-HgR commercial formulation required ≥2x109 cfu to elicit high seroconversion in developing country populations...
October 11, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28835360/chlamydia-trachomatis-the-persistent-pathogen
#25
REVIEW
Steven S Witkin, Evelyn Minis, Aikaterini Athanasiou, Julie Leizer, Iara M Linhares
Chlamydia trachomatis is an obligate intracellular bacterium whose only natural host is humans. Although presenting as asymptomatic in most women, genital tract chlamydial infections are a leading cause of pelvic inflammatory disease, tubal factor infertility, and ectopic pregnancy. C. trachomatis has evolved successful mechanisms to avoid destruction by autophagy and the host immune system and persist within host epithelial cells. The intracellular form of this organism, the reticulate body, can enter into a persistent nonreplicative but viable state under unfavorable conditions...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28835359/mother-newborn-pairs-in-malawi-have-similar-antibody-repertoires-to-diverse-malaria-antigens
#26
RANDOMIZED CONTROLLED TRIAL
Sarah Boudová, Jenny A Walldorf, Jason A Bailey, Titus Divala, Randy Mungwira, Patricia Mawindo, Jozelyn Pablo, Algis Jasinskas, Rie Nakajima, Amed Ouattara, Matthew Adams, Philip L Felgner, Christopher V Plowe, Mark A Travassos, Miriam K Laufer
Maternal antibodies may play a role in protecting newborns against malaria disease. Plasmodium falciparum parasite surface antigens are diverse, and protection from infection requires allele-specific immunity. Although malaria-specific antibodies have been shown to cross the placenta, the extent to which antibodies that respond to the full repertoire of diverse antigens are transferred from the mother to the infant has not been explored. Understanding the breadth of maternal antibody responses and to what extent these antibodies are transferred to the child can inform vaccine design and evaluation...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28835358/combined-action-of-human-commensal-bacteria-and-amorphous-silica-nanoparticles-on-the-viability-and-immune-responses-of-dendritic-cells
#27
JOURNAL ARTICLE
Giulia Malachin, Elisa Lubian, Fabrizio Mancin, Emanuele Papini, Regina Tavano
Dendritic cells (DCs) regulate the host-microbe balance in the gut and skin, tissues likely exposed to nanoparticles (NPs) present in drugs, food, and cosmetics. We analyzed the viability and the activation of DCs incubated with extracellular media (EMs) obtained from cultures of commensal bacteria ( Escherichia coli , Staphylococcus epidermidis ) or pathogenic bacteria ( Pseudomonas aeruginosa , Staphylococcus aureus ) in the presence of amorphous silica nanoparticles (SiO2 NPs). EMs and NPs synergistically increased the levels of cytotoxicity and cytokine production, with different nanoparticle dose-response characteristics being found, depending on the bacterial species...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28814389/equine-arteritis-virus-elicits-a-mucosal-antibody-response-in-the-reproductive-tract-of-persistently-infected-stallions
#28
JOURNAL ARTICLE
Mariano Carossino, Bettina Wagner, Alan T Loynachan, R Frank Cook, Igor F Canisso, Lakshman Chelvarajan, Casey L Edwards, Bora Nam, John F Timoney, Peter J Timoney, Udeni B R Balasuriya
Equine arteritis virus (EAV) has the ability to establish persistent infection in the reproductive tract of the stallion (carrier) and is continuously shed in its semen. We have recently demonstrated that EAV persists within stromal cells and a subset of lymphocytes in the stallion accessory sex glands in the presence of a significant local inflammatory response. In the present study, we demonstrated that EAV elicits a mucosal antibody response in the reproductive tract during persistent infection with homing of plasma cells into accessory sex glands...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28814388/impact-of-poxvirus-vector-priming-protein-coadministration-and-vaccine-intervals-on-hiv-gp120-vaccine-elicited-antibody-magnitude-and-function-in-infant-macaques
#29
JOURNAL ARTICLE
Bonnie Phillips, Genevieve G Fouda, Josh Eudailey, Justin Pollara, Alan D Curtis, Erika Kunz, Maria Dennis, Xiaoying Shen, Camden Bay, Michael Hudgens, David Pickup, S Munir Alam, Amir Ardeshir, Pamela A Kozlowski, Koen K A Van Rompay, Guido Ferrari, M Anthony Moody, Sallie Permar, Kristina De Paris
Despite success in reducing vertical HIV transmission by maternal antiretroviral therapy, several obstacles limit its efficacy during breastfeeding, and breast-milk transmission is now the dominant mode of mother-to-child transmission (MTCT) of HIV in infants. Thus, a pediatric vaccine is needed to eradicate oral HIV infections in newborns and infants. Utilizing the infant rhesus macaque model, we compared 3 different vaccine regimens: (i) HIV envelope (Env) protein only, (ii) poxvirus vector (modified vaccinia virus Ankara [MVA])-HIV Env prime and HIV Env boost, and (iii) coadministration of HIV Env and MVA-HIV Env at all time points...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28768669/immunogenicity-of-nontypeable-haemophilus-influenzae-outer-membrane-vesicles-and-protective-ability-in-the-chinchilla-model-of-otitis-media
#30
JOURNAL ARTICLE
Linda E Winter, Stephen J Barenkamp
Outer membrane vesicles (OMVs) produced by Gram-negative bacteria are enriched in several outer membrane components, including major and minor outer membrane proteins and lipooligosaccharide. We assessed the functional activity of nontypeable Haemophilus influenzae (NTHi) OMV-specific antisera and the protective ability of NTHi OMVs as vaccine antigens in the chinchilla otitis media model. OMVs were purified from three HMW1/HMW2-expressing NTHi strains, two of which were also engineered to overexpress Hia proteins...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28768668/a-combination-of-recombinant-mycobacterium-bovis-bcg-strains-expressing-pneumococcal-proteins-induces-cellular-and-humoral-immune-responses-and-protects-against-pneumococcal-colonization-and-sepsis
#31
JOURNAL ARTICLE
Cibelly Goulart, Dunia Rodriguez, Alex I Kanno, Thiago Rojas Converso, Ying-Jie Lu, Richard Malley, Luciana C C Leite
Pneumococcal diseases remain a substantial cause of mortality in young children in developing countries. The development of potentially serotype-transcending vaccines has been extensively studied; ideally, such a vaccine should include antigens that are able to induce protection against colonization (likely mediated by interleukin-17A [IL-17A]) and invasive disease (likely mediated by antibody). The use of strong adjuvants or alternative delivery systems that are able to improve the immunological response of recombinant proteins has been proposed but poses potential safety and practical concerns in children...
October 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28903988/the-use-of-reverse-vaccinology-in-the-design-and-construction-of-nano-glycoconjugate-vaccines-against-burkholderia-pseudomallei
#32
JOURNAL ARTICLE
Laura A Muruato, Daniel Tapia, Christopher L Hatcher, Mridul Kalita, Paul J Brett, Anthony E Gregory, James E Samuel, Richard W Titball, Alfredo G Torres
Burkholderia pseudomallei (Bpm ) is a Gram negative, facultative intracellular pathogen that causes the disease melioidosis in humans and other mammals. Respiratory infection with B. pseudomallei leads to a fulminant and often fatal disease. It has previously been shown that glycoconjugate vaccines can provide significant protection against lethal challenge; however, the limited number of known Burkholderia antigens has slowed progress towards vaccine development. The objective of this study was to identify novel antigens and evaluate their protective capacity when incorporated into a nano-glycoconjugate vaccine platform...
September 13, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28701468/rubella-surveillance-and-diagnostic-testing-among-a-low-prevalence-population-new-york-city-2012-2013
#33
JOURNAL ARTICLE
Beth M Isaac, Jane R Zucker, Francesca R Giancotti, Emily Abernathy, Joseph Icenogle, Jennifer L Rakeman, Jennifer B Rosen
The New York City Department of Health and Mental Hygiene (DOHMH) receives clinical and laboratory reports for rubella. Because rubella immunoglobulin M (IgM) assays may produce false-positive results and rubella infections may be asymptomatic, interpretation of positive IgM results can be challenging. Rubella reports received by DOHMH in 2012 to 2013 were reviewed. The rubella IgM testing purpose was determined through case investigation. Results of IgM testing by indirect enzyme-linked immunosorbent assay (ELISA) and capture enzyme immunoassay (EIA) were compared to determine positive predictive value (PPV) and specificity...
September 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28701467/the-cross-species-mycobacterial-growth-inhibition-assay-mgia-project-2010-2014
#34
REVIEW
Michael J Brennan, Rachel Tanner, Sheldon Morris, Thomas J Scriba, Jacqueline M Achkar, Andrea Zelmer, David A Hokey, Angelo Izzo, Sally Sharpe, Ann Williams, Adam Penn-Nicholson, Mzwandile Erasmus, Elena Stylianou, Daniel F Hoft, Helen McShane, Helen A Fletcher
The development of a functional biomarker assay in the tuberculosis (TB) field would be widely recognized as a major advance in efforts to develop and to test novel TB vaccine candidates efficiently. We present preliminary studies using mycobacterial growth inhibition assays (MGIAs) to detect Mycobacterium bovis BCG vaccine responses across species, and we extend this work to determine whether a standardized MGIA can be applied in characterizing new TB vaccines. The comparative MGIA studies reviewed here aimed to evaluate robustness, reproducibility, and ability to reflect in vivo responses...
September 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28679495/dose-selection-for-an-adjuvanted-respiratory-syncytial-virus-f-protein-vaccine-for-older-adults-based-on-humoral-and-cellular-immune-responses
#35
RANDOMIZED CONTROLLED TRIAL
Judith Falloon, H Keipp Talbot, Craig Curtis, John Ervin, Diane Krieger, Filip Dubovsky, Therese Takas, Jing Yu, Li Yu, Stacie L Lambert, Tonya Villafana, Mark T Esser
This is the second phase 1 study of a respiratory syncytial virus (RSV) vaccine containing RSV fusion protein (sF) adjuvanted with glucopyranosyl lipid A (GLA) in a squalene-based 2% stable emulsion (GLA-SE). In this randomized, double-blind study, 261 subjects aged ≥60 years received inactivated influenza vaccine (IIV), a vaccine containing 120 μg sF with escalating doses of GLA (1, 2.5, or 5 μg) in SE, or a vaccine containing 80 μg sF with 2.5 μg GLA in SE. Subjects receiving 120 μg sF with 2.5 or 5 μg GLA were also randomized to receive IIV or placebo...
September 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28659325/identification-of-an-atypical-enzootic-bovine-leukosis-in-japan-by-using-a-novel-classification-of-bovine-leukemia-based-on-immunophenotypic-analysis
#36
JOURNAL ARTICLE
Asami Nishimori, Satoru Konnai, Tomohiro Okagawa, Naoya Maekawa, Shinya Goto, Ryoyo Ikebuchi, Ayako Nakahara, Yuzumi Chiba, Masaho Ikeda, Shiro Murata, Kazuhiko Ohashi
Bovine leukemia is classified into two types: enzootic bovine leukosis (EBL) and sporadic bovine leukosis (SBL). EBL is caused by infection with bovine leukemia virus (BLV), which induces persistent lymphocytosis and B-cell lymphoma in cattle after a long latent period. Although it has been demonstrated that BLV-associated lymphoma occurs predominantly in adult cattle of >3 to 5 years, suspicious cases of EBL onset in juvenile cattle were recently reported in Japan. To investigate the current status of bovine leukemia in Japan, we performed immunophenotypic analysis of samples from 50 cattle that were clinically diagnosed as having bovine leukemia...
September 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28794055/effect-of-vaccine-elicited-antibodies-on-colonization-of-neisseria-meningitidis-serogroup-b-and-c-strains-in-a-human-bronchial-epithelial-cell-culture-model
#37
JOURNAL ARTICLE
Vianca Vianzon, Beate Illek, Gregory R Moe
Capsular polysaccharide-protein conjugate vaccines protect individuals from invasive disease and decrease carriage, which reduces spread of the organism in the population. In contrast, antibodies elicited by plain polysaccharide or protein antigen-based meningococcal (Men) vaccines have little or no effect on decreasing carriage. In this study, we investigated the mechanism by which vaccine-induced human IgG antibodies affect colonization by serogroup B (MenB) or C (MenC) strains using a human bronchial epithelial cell culture model (16HBE14o-)...
August 9, 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28637806/the-pneumococcal-serotype-15c-capsule-is-partially-o-acetylated-and-allows-for-limited-evasion-of-23-valent-pneumococcal-polysaccharide-vaccine-elicited-anti-serotype-15b-antibodies
#38
JOURNAL ARTICLE
Brady L Spencer, Anukul T Shenoy, Carlos J Orihuela, Moon H Nahm
As a species, Streptococcus pneumoniae (the pneumococcus) utilizes a diverse array of capsular polysaccharides to evade the host. In contrast to large variations in sugar composition and linkage formation, O-acetylation is a subtle capsular modification that nonetheless has a large impact on capsular shielding and recognition of the capsule by vaccine-elicited antibodies. Serotype 15B, which is included in the 23-valent pneumococcal polysaccharide vaccine (PPV23), carries the putative O-acetyltransferase gene wciZ The coding sequence of wciZ contains eight consecutive TA repeats [(TA)8 ]...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28637805/conjugation-of-pspa4pro-with-capsular-streptococcus-pneumoniae-polysaccharide-serotype-14-does-not-reduce-the-induction-of-cross-reactive-antibodies
#39
JOURNAL ARTICLE
Míriam A da Silva, Thiago R Converso, Viviane M Gonçalves, Luciana C C Leite, Martha M Tanizaki, Giovana C Barazzone
Current pneumococcal vaccines are composed of bacterial polysaccharides as antigens, plain or conjugated to carrier proteins. While efficacious against vaccine serotypes, epidemiologic data show an increasing incidence of infections caused by nonvaccine serotypes of Streptococcus pneumoniae The use of pneumococcal surface protein A (PspA) as a carrier protein in a conjugate vaccine could help prevent serotype replacement by increasing vaccine coverage and reducing selective pressure of S. pneumoniae serotypes...
August 2017: Clinical and Vaccine Immunology: CVI
https://read.qxmd.com/read/28637804/bioactive-immune-components-of-anti-diarrheagenic-enterotoxigenic-escherichia-coli-hyperimmune-bovine-colostrum-products
#40
JOURNAL ARTICLE
Khandra T Sears, Sharon M Tennant, Mardi K Reymann, Raphael Simon, Nicky Konstantopoulos, William C Blackwelder, Eileen M Barry, Marcela F Pasetti
Diarrhea is a common illness among travelers to resource-limited countries, the most prevalent attributable agent being enterotoxigenic Escherichia coli (ETEC). At this time, there are no vaccines licensed specifically for the prevention of ETEC-induced traveler's diarrhea (TD), and this has propelled investigation of alternative preventive methods. Colostrum, the first milk expressed after birthing, is rich in immunoglobulins and innate immune components for protection of newborns against infectious agents...
August 2017: Clinical and Vaccine Immunology: CVI
journal
journal
41110
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.